Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579813 · ClinicalTrials.gov registry record · Phase 4
Mechanisms Underlying Metabolic Syndrome in Obesity
A Phase 4 study, sponsored by Philip Kern.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00579813 is a Phase 4 study that has completed, run by Philip Kern. The registered enrollment target is 70 participants.
The verdict
NCT00579813, a Phase 4 study, has completed, sponsored by Philip Kern.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the link between obesity and diabetes or pre-diabetes.
Interventions
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579813
The ClinicalTrials.gov registry entry for NCT00579813 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Kern, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pioglitazone is the first listed.
NCT00579813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579813 about?
NCT00579813 is a clinical study titled "Mechanisms Underlying Metabolic Syndrome in Obesity". The purpose of this study is to better understand the link between obesity and diabetes or pre-diabetes.
What is the current status of trial NCT00579813?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2005-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00579813?
The interventions under investigation include: Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00579813?
This trial is sponsored by Philip Kern, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.